Manfaat Vaksinasi Influenza bagi Pasien Diabetes Melitus

Rudy Kurniawan (Internal medicine specialist, Diabetes Connection & Care, Eka Hospital BSD, South Tangerang, Indonesia)
Dicky Levenus Tahapary (Klinik Metabolik, Kardiovaskular dan Penuaan, Lembaga Penelitian dan Pendidikan Kedokteran Indonesia, Fakultas Kedokteran Universitas Indonesia, Jakarta, Indonesia, Divisi Endokrinologi, Metabolik, dan Diabetes, Departemen Ilmu Penyakit Dalam, Rumah )

Cermin Dunia Kedokteran
Vol 51 No 3 (2024): Neurologi

People with diabetes mellitus have a dysregulated immune system and are more susceptible to infection, which poses a higher risk of severe influenza complications. Current evidence for influenza vaccine effectiveness in people with diabetes mellitus indicates a beneficial reduction of morbidity and mortality. In addition, serological studies show antibody levels elicited from influenza vaccination in diabetes patients show comparable results with healthy adults. Although more controlled clinical trials in diabetes mellitus patients with influenza are needed to reflect the effect of vaccination, current data indicate the need for routine influenza vaccination in diabetes mellitus patients, as recommended by guidelines. Efforts should be made to increase vaccination coverage in this risk group.